Cellectar Biosciences, Inc. - Common Stock (CLRB)

CUSIP: 15117F880

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+50,684
SEC-reported price per share
$2.95
Indexed holders
19
Value change
-$210
Number of buys
11
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,452,102

Security key

15117F880

Report period

Q4 2025

Indexed institutions

19

Top holders

10

Ownership snapshot

Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
Orin Hirschman
Comparable rows
7/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 5.5% 8 rows are not safely comparable across share classes. 13D/G row: Rosalind Advisors, Inc. Showing 1-6 of 15 holder rows.

Quick read

Rosalind Advisors, Inc. leads the comparable SEC ownership view at 5.5%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rosalind Advisors, Inc.'s linked filing trail.
Comparable ownership Top 5
Rosalind Advisors, Inc. 5.5%
INTRACOASTAL CAPITAL, LLC 5%
Orin Hirschman 4.9%
Hexstone Capital LLC 4.9%
Laurence W. Lytton 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rosalind Advisors, Inc.
13D/G
5.5%
Reported 13D/G · 31 Dec 2025
—
247,715 shares
$0 31 Dec 2025
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
Reported 13D/G · 01 Jul 2025
—
140,101 shares
$0 01 Jul 2025
Orin Hirschman
13D/G
4.9%
Reported 13D/G · 31 Dec 2024
$586,444
2,022,221 shares
$0 31 Dec 2024
Hexstone Capital LLC
13D/G
4.9%
Reported 13D/G · 31 Dec 2025
$553,293
216,130 shares
+$169,293 31 Dec 2025
Laurence W. Lytton
13D/G
LYTTON LAURENCE W
1.6%
Reported 13D/G · 30 Jun 2025
$250,788
51,391 shares
$0 30 Jun 2025
ADAR1 Capital Management, LLC
13D/G
0.1%
Reported 13D/G · 30 Jun 2025
—
2,962 shares
$0 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
19
Shares
336,454
Indexed holders
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
21
Q4 2025 indexed holders
19
Indexed holder difference
-2
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .